Pennsylvania | 23-2472830 | |
(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) |
Mitchell S. Bloom, Esq.
|
Kathryn L. Biberstein, Esq. | |
Robert E. Puopolo
|
Alkermes, Inc. | |
Goodwin Procter LLP
|
88 Sidney Street | |
53 State Street
|
Cambridge, MA 02139 | |
Boston, MA 02109
|
Telephone: (617) 583-6255 | |
Telephone: (617) 570-1055 |
Proposed Maximum | Proposed Maximum | |||||||||||||||||||||
Amount to be | Offering Price Per | Aggregate Offering | Amount of | |||||||||||||||||||
Title of Securities | Registered (1)(3) | Share | Price | Registration Fee | ||||||||||||||||||
Common Stock |
300,000 | $ | 14.69 | (2) | $ | 4,407,000 | $ | 471.55 | ||||||||||||||
Totals: |
300,000 | $ | 4,407,000 | $ | 471.55 | |||||||||||||||||
(1) | Pursuant to Rule 416 under the Securities Act of 1933, this registration statement shall also be deemed to cover an indeterminate number of additional shares of Common Stock issuable in the event the number of outstanding shares of the Company is increased by split-up, reclassification, stock dividend, recapitalization, and certain other capital adjustments and the like. | |
(2) | Estimated solely for the purpose of calculating the registration fee. In accordance with Rules 457(c) and 457(h), the proposed maximum offering price per share, the proposed maximum aggregate offering price, and the registration fee shown has been computed based upon the average of the high and low sales price of the Companys Common Stock on September 15, 2006, $14.69, as reported on the Nasdaq Global Market with respect to securities for which options have not been granted. | |
(3) | This registration statement relates 300,000 shares of Common Stock, $.01 par value per share, reserved for issuance under the 2002 Restricted Stock Award Plan (the 2002 Plan), which shares are in addition to 500,000 shares of Common Stock, $0.01 par value per share, previously registered pursuant to Registration Statements on Form S-8 (Registration Nos. 333-107208) and filed with the Securities and Exchange Commission. The current filing is being made to register the 300,000 shares which are issuable under the 2002 Plan. |
(a) | Annual Report on Form 10-K for the fiscal year ended March 31, 2006 filed on June 14, 2006 and as amended by an Amendment No. 1 to Annual Report on Form 10-K/A for the fiscal year ended March 31, 2006 filed on August 14, 2006; | |
(b) | Quarterly Report on Form 10-Q for the period ended June 30, 2006; | |
(c) | All other documents filed by the Company pursuant to 13(a) or 15(d) of the Exchange Act since the end of the fiscal year covered by the document referred to in (a) above; and | |
(d) | Item 1 of Registration Statement of the Company on Form 8-A dated June 28, 1991, as amended by a Registration Statement of the Company on Form 8-A/A dated January 17, 1997; and Item 1 of Registration Statement of the Company on Form 8-A dated May 2, 2003. |
ALKERMES, INC. |
||||
By: | /s/ Richard F. Pops | |||
Richard F. Pops | ||||
Chief Executive Officer | ||||
SIGNATURE | TITLE | DATE | ||
/s/ Michael A. Wall
|
Director and Chairman of the Board | September 21, 2006 | ||
/s/ Richard F. Pops
|
Director and Chief Executive Officer (Principal Executive Officer) |
September 21, 2006 | ||
/s/ James M. Frates
|
Vice President, Chief Financial Officer and Treasurer (Principal Financial and Accounting Officer) | September 21, 2006 | ||
/s/ Floyd E. Bloom
|
Director | September 21, 2006 | ||
/s/ Robert A. Breyer
|
Director | September 21, 2006 | ||
/s/ Gerri Henwood
|
Director | September 21, 2006 | ||
/s/ Paul J. Mitchell
|
Director | September 21, 2006 | ||
/s/ Alexander Rich
|
Director | September 21, 2006 | ||
/s/ Paul Schimmel
|
Director | September 21, 2006 | ||
/s/ Mark B. Skaletsky
|
Director | September 21, 2006 |
Exhibit No. | Description of Exhibit | |
4.1
|
Specimen of Common Stock Certificate of Alkermes, Inc. (Incorporated by reference to Exhibit 4 to the Registrants Registration Statement on Form S-1, as amended (File No. 33-40250).) | |
4.2
|
Specimen of Non-Voting Common Stock Certificate of Alkermes, Inc. (Incorporated by reference to Exhibit 4.2 to the Registrants Registration Statement on Form S-8, as amended, filed on April 22, 2005). | |
4.3
|
Specimen of 2002 Preferred Stock Certificate of Alkermes, Inc. (Incorporated by reference to Exhibit 4.1 to the Registrants Report on Form 8-K filed on December 13, 2002.) | |
4.4
|
Indenture, dated as of February 18, 2000, between Alkermes, Inc. and State Street Bank and Trust Company, as Trustee. (3.75% Subordinated Notes) (Incorporated by reference to Exhibit 4.6 to the Registrants Registration Statement on Form S-3, as amended, filed on February 29, 2000 (File No. 333-31354).) | |
4.5
|
Form of 3.75% Subordinated Note (Incorporated by reference to Exhibit 4.6 to the Registrants Registration Statement on Form S-3, as amended, filed on February 29, 2000 (File No. 333-31354).) | |
4.6
|
Rights Agreement, dated as of February 7, 2003, as amended, between Alkermes, Inc. and EquiServe Trust Co., N.A., as Rights Agent. (Incorporated by reference to Exhibit 4.1 to the Registrants Report on Form 8-A filed on May 2, 2003.) | |
4.7
|
Indenture, dated February 1, 2005, between RC Royalty Sub LLC and U.S. Bank National Association, as Trustee (Risperdal Consta ® PhaRMA (SM) secured 7% Notes due 2018, Class A). (Incorporated by reference to Exhibit 4.1 to Registrants Report on Form 8-K filed on February 3, 2005) (File No. 001-14131).) | |
4.8
|
Form of Risperdal Consta ® PhaRMA (SM) secured 7% Notes due 2018, Class A (Incorporated by reference to Exhibit A to Exhibit 4.1 to the Registrants Report on Form 8-K filed on February 3, 2005) (File No. 001-14131).) | |
4.9
|
Alkermes, Inc. 1999 Stock Option Plan, as amended (Incorporated by reference to Exhibit 10.1 to the Registrants Report on Form 10-Q for the quarter ended September 30, 2004) (File No. 001-14131).) | |
4.10
|
Form of Stock Option Certificate pursuant to the 1999 Stock Option Plan, as amended (Incorporated by reference to Exhibit 10.36 to the Registrants Report on Form 10-K for the year ended March 31, 2006) | |
5.1
|
Opinion of Ballard Spahr Andrews & Ingersoll (filed herewith). | |
23.1
|
Consent of Ballard Spahr Andrews & Ingersoll (included in Exhibit 5.1). | |
23.2
|
Consent of Deloitte & Touche LLP (filed herewith). | |
24.1
|
Power of Attorney (included in signature page). |